GB9624411D0 - Diagnosis of prion diseases - Google Patents

Diagnosis of prion diseases

Info

Publication number
GB9624411D0
GB9624411D0 GBGB9624411.6A GB9624411A GB9624411D0 GB 9624411 D0 GB9624411 D0 GB 9624411D0 GB 9624411 A GB9624411 A GB 9624411A GB 9624411 D0 GB9624411 D0 GB 9624411D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
prion diseases
prion
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9624411.6A
Other versions
GB2319607A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteome Sciences PLC
Original Assignee
Electrophoretics International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Electrophoretics International PLC filed Critical Electrophoretics International PLC
Priority to GB9624411A priority Critical patent/GB2319607A/en
Publication of GB9624411D0 publication Critical patent/GB9624411D0/en
Priority to EP97913294A priority patent/EP0937260A1/en
Priority to JP52633398A priority patent/JP2001508866A/en
Priority to AU50597/98A priority patent/AU737326B2/en
Priority to CA002271318A priority patent/CA2271318A1/en
Priority to PCT/GB1997/003135 priority patent/WO1998023962A1/en
Publication of GB2319607A publication Critical patent/GB2319607A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GB9624411A 1996-11-23 1996-11-23 Detection of prion proteins in mononuclear cells Withdrawn GB2319607A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB9624411A GB2319607A (en) 1996-11-23 1996-11-23 Detection of prion proteins in mononuclear cells
EP97913294A EP0937260A1 (en) 1996-11-23 1997-11-24 Diagnosis of prion diseases
JP52633398A JP2001508866A (en) 1996-11-23 1997-11-24 Diagnosis of prion disease
AU50597/98A AU737326B2 (en) 1996-11-23 1997-11-24 Diagnosis of prion diseases
CA002271318A CA2271318A1 (en) 1996-11-23 1997-11-24 Diagnosis of prion diseases
PCT/GB1997/003135 WO1998023962A1 (en) 1996-11-23 1997-11-24 Diagnosis of prion diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9624411A GB2319607A (en) 1996-11-23 1996-11-23 Detection of prion proteins in mononuclear cells

Publications (2)

Publication Number Publication Date
GB9624411D0 true GB9624411D0 (en) 1997-01-08
GB2319607A GB2319607A (en) 1998-05-27

Family

ID=10803399

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9624411A Withdrawn GB2319607A (en) 1996-11-23 1996-11-23 Detection of prion proteins in mononuclear cells

Country Status (6)

Country Link
EP (1) EP0937260A1 (en)
JP (1) JP2001508866A (en)
AU (1) AU737326B2 (en)
CA (1) CA2271318A1 (en)
GB (1) GB2319607A (en)
WO (1) WO1998023962A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI982480A0 (en) * 1998-11-17 1998-11-17 Wallac Oy Immunoassay for the detection of infectious spongiform encephalopathy in mammals
FI982481A0 (en) * 1998-11-17 1998-11-17 Wallac Oy Immunoassay for the detection of infectious bovine spongiform encephalopathy
US6605445B1 (en) 1999-02-22 2003-08-12 Bayer Corporation Rapid method of determining clearance of prion protein
US6166187A (en) 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
ATE327346T1 (en) * 1999-10-27 2006-06-15 Univ Liege IMMUNO-REAL-TIME PCR USING A DNA CHIMER AS AN AMPLIFICATION MARKER
DK1261875T3 (en) 2000-03-10 2007-11-26 Univ Geneve Diagnostic analysis for transmissible spongiform encephalopathy
GB2360089A (en) * 2000-03-10 2001-09-12 Univ Geneve Diagnostic assay for transmisible spongiform encephalopathies
EP1249500A1 (en) * 2001-04-12 2002-10-16 chimera biotec GmbH Method for the determination of an analyte
GB0110172D0 (en) * 2001-04-25 2001-06-20 Pa Consulting Services Improved analytical test approach for blood
EP1556702A2 (en) 2002-10-30 2005-07-27 Proteome Sciences Plc Diagnostic methods for transmissible spongiform encephalopathies (prion diseases)
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
WO2005070968A1 (en) * 2004-01-21 2005-08-04 Wako Pure Chemical Industries, Ltd. Protein immobilization method and quantification method
EP1596199A1 (en) * 2004-05-14 2005-11-16 Prionics AG Method for the detection of disease-related prion
US20130109581A1 (en) 2009-11-04 2013-05-02 David Peretz Positively charged species as binding reagents in the separation of protein aggregates from monomers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4233604B2 (en) * 1991-12-03 2009-03-04 プロセリックス メディスンズ ディベロップメント リミテッド Prion protein fragment
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
SK67797A3 (en) * 1994-11-29 2000-02-14 Mini Agriculture & Fisheries Spongiform encephalopathy detection methods
EP1416280A3 (en) * 1995-09-14 2005-08-10 The Regents of the University of California Antibodies specific for native PrPsc
DK0891552T4 (en) * 1996-04-03 2009-05-04 Stichting Dienst Landbouwkundi Method for detecting prion diseases
US5998149A (en) * 1996-04-05 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Method of detecting transmissible spongiform encephalopathies

Also Published As

Publication number Publication date
EP0937260A1 (en) 1999-08-25
AU737326B2 (en) 2001-08-16
CA2271318A1 (en) 1998-06-04
WO1998023962A8 (en) 2000-02-17
GB2319607A (en) 1998-05-27
AU5059798A (en) 1998-06-22
JP2001508866A (en) 2001-07-03
WO1998023962A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
GB2317778B (en) Endoscope
EP1008882A4 (en) Objective of endoscope
IL113872A0 (en) Tissue monitor
AU9083098A (en) Diagnosis of ocular pathogens
EP0964250A4 (en) Diagnostic drugs for autoimmune diseases
GB9624411D0 (en) Diagnosis of prion diseases
EP0757696A4 (en) Human sperm diagnostic
AU2513997A (en) Diagnosis and monitoring of neurological disease
GB2361872B (en) Diagnosis of medical disorders
IL117146A0 (en) Diagnosis of lung condition
EP0790062A4 (en) Remedy for heart diseases
EP0815133A4 (en) Human stat4
HUP9901448A3 (en) Novel medical use
GB9805913D0 (en) Diagnosis of ms
GB9526691D0 (en) Medical use of proteases
EP0783891A4 (en) Remedy for bone diseases
GB9614615D0 (en) Diagnosis of pre-eclampsia
GB9825948D0 (en) Diagnosis of spongiform disease
AU1764897A (en) Arrangement for determining the state of curvature of areas of the human body
GB2354946B (en) Means for the treatment of prion disease
EP0797592A4 (en) Human stanniocalcin-alpha
ZA947865B (en) Human glactokinase
GB9523473D0 (en) Diagnosis of toxicoinfectious clostridiosis
GB9502739D0 (en) Diagnosis of toxicoinfections clostridiosis
EP0842187A4 (en) Human cystatin e

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)